ASBP
Aspire BioPharma, Inc.
NASDAQ: ASBP · HEALTHCARE · BIOTECHNOLOGY
$0.22
-9.30% today
Updated 2026-04-30
Market cap
$1.03M
P/E ratio
—
P/S ratio
166.07x
EPS (TTM)
$-16.38
Dividend yield
—
52W range
$0 – $35
Volume
12.1M
Aspire BioPharma, Inc. (ASBP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-15.8%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-17.5%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-31.3%
2025-09-30
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.33 | — | $0.14 | $0.14 | -3.6% |
| 2025-09-30 | $-1.49 | — | $0.31 | $0.21 | -31.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $-1.33 | — | $4261.00 | — |
| 2025-09-30 | — | $-1.49 | — | $1941.00 | — |
| 2025-06-30 | — | $-0.04 | — | — | — |
| 2025-03-31 | — | $-0.42 | — | — | — |
| 2024-12-31 | — | $-1.15 | — | — | — |
| 2024-09-30 | — | $-2.77 | — | — | — |
| 2024-06-30 | — | $-2.85 | — | — | — |
| 2024-03-31 | — | $-10.98 | — | — | — |
| 2023-12-31 | — | $-0.67 | — | — | — |
| 2023-09-30 | — | $-0.31 | — | — | — |
| 2023-06-30 | — | $2.28 | — | — | — |
| 2023-03-31 | — | $0.08 | — | — | — |
Frequently asked questions
Has Aspire BioPharma, Inc. beaten earnings estimates?
Aspire BioPharma, Inc. has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports.
How does ASBP stock react to earnings?
ASBP stock has moved an average of -17.5% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.